Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Meignan

Showing results (81-90 of 125) with videos related to

Pageof 13
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 21, 2023
Validation of the ΔSUV<sub>max</sub> for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical TrialEmmanuel Itti, Paul Blanc-Durand, Alina Berriolo-Riedinger, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 24, 2015
(99m)Tc-HMDP scintigraphy rectifies wrong diagnosis of AL amyloidosisArnault Galat, Axel Van Der Gucht, Magali Colombat, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 3, 2017
Predictive Value of PET Response Combined with Baseline Metabolic Tumor Volume in Peripheral T-Cell Lymphoma PatientsAnne-Ségolène Cottereau, Tarec Christoffer El-Galaly, Stéphanie Becker, et al.
Blood|March 3, 2017
Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association reportMira Tout, Olivier Casasnovas, Michel Meignan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 24, 2020
Fully automatic segmentation of diffuse large B cell lymphoma lesions on 3D FDG-PET/CT for total metabolic tumour volume prediction using a convolutional neural networkPaul Blanc-Durand, Simon Jégou, Salim Kanoun, et al.
European Radiology|March 24, 2010
Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphomaChieh Lin, Alain Luciani, Emmanuel Itti, et al.
Blood|April 27, 2011
SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphomaRené-Olivier Casasnovas, Michel Meignan, Alina Berriolo-Riedinger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 21, 2014
PET/CT before autologous stem cell transplantation predicts outcome in refractory/relapsed follicular lymphomaMarion Alcantara, Jehan Dupuis, Sylvain Mareschal, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
Deep Learning Approach to Automatize TMTV Calculations Regardless of Segmentation Methodology for Major FDG-Avid LymphomasWendy Revailler, Anne Ségolène Cottereau, Cedric Rossi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 7, 2014
Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphomaMyriam Sasanelli, Michel Meignan, Corinne Haioun, et al.
Pageof 13

Showing results (81-90 of 125) with videos related to

Sort By:
Pageof 13
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 21, 2023
Validation of the ΔSUV<sub>max</sub> for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical TrialEmmanuel Itti, Paul Blanc-Durand, Alina Berriolo-Riedinger, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 24, 2015
(99m)Tc-HMDP scintigraphy rectifies wrong diagnosis of AL amyloidosisArnault Galat, Axel Van Der Gucht, Magali Colombat, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 3, 2017
Predictive Value of PET Response Combined with Baseline Metabolic Tumor Volume in Peripheral T-Cell Lymphoma PatientsAnne-Ségolène Cottereau, Tarec Christoffer El-Galaly, Stéphanie Becker, et al.
Blood|March 3, 2017
Rituximab exposure is influenced by baseline metabolic tumor volume and predicts outcome of DLBCL patients: a Lymphoma Study Association reportMira Tout, Olivier Casasnovas, Michel Meignan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 24, 2020
Fully automatic segmentation of diffuse large B cell lymphoma lesions on 3D FDG-PET/CT for total metabolic tumour volume prediction using a convolutional neural networkPaul Blanc-Durand, Simon Jégou, Salim Kanoun, et al.
European Radiology|March 24, 2010
Whole-body diffusion-weighted magnetic resonance imaging with apparent diffusion coefficient mapping for staging patients with diffuse large B-cell lymphomaChieh Lin, Alain Luciani, Emmanuel Itti, et al.
Blood|April 27, 2011
SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphomaRené-Olivier Casasnovas, Michel Meignan, Alina Berriolo-Riedinger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 21, 2014
PET/CT before autologous stem cell transplantation predicts outcome in refractory/relapsed follicular lymphomaMarion Alcantara, Jehan Dupuis, Sylvain Mareschal, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
Deep Learning Approach to Automatize TMTV Calculations Regardless of Segmentation Methodology for Major FDG-Avid LymphomasWendy Revailler, Anne Ségolène Cottereau, Cedric Rossi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 7, 2014
Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphomaMyriam Sasanelli, Michel Meignan, Corinne Haioun, et al.
Pageof 13